
News|Articles|December 16, 2025
A look into the volume of Quest lab data for CKD research
Author(s)Quest Diagnostics
This datasheet illustrates how Quest Diagnostics' extensive de-identified lab data can be leveraged to accelerate and optimize clinical trials for Chronic Kidney Disease (CKD). Researchers can use this real-world data to identify high concentrations of eligible patients, select optimal trial sites, find suitable principal investigators, and drive targeted patient recruitment efforts.
Trending on Applied Clinical Trials Online
1
Agentic RTSM and the Push to Compress Clinical Trial Startup: Q&A with Robert Hummel, Suvoda
2
Why Clinical Trials Need an Execution Architecture Before AI Can Deliver: Q&A with Abraham Gutman, AG Mednet
3
AI-Driven Clinical Trial Recruitment and Design
4
How RBQM Needs to Evolve for a Real-Time Oversight World
5